Andere Sprachen BioPharma Credit PLC

Aktien

A2DN3S

GB00BDGKMY29

BPCP

Verzögert London S.E. Andere Börsenplätze 13:46:27 23.04.2024			% 5 Tage	% 1. Jan.
0.878 ^USD	+0.22%		+0.23%	+4.52%

27.03.	BioPharma Credit PLC meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr	CI
27.03.	Vorstand und Investmentmanager von BioPharma Credit schlagen Änderungen am Rabattkontrollmechanismus vor	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

BioPharma Credit PLC Reports Earnings Results for the Full Year Ended December 31, 2023	27.03.
BioPharma Credit net asset value ticks up but total payout lower	27.03.
BioPharma Credit Board, Investment Manager Propose Changes to Discount Control Mechanism	27.03.
BioPharma Credit Logs Lower FY23 Net Income Return on Ordinary Activities	27.03.
Tranche Update on BioPharma Credit PLC's Equity Buyback Plan announced on May 31, 2023.	27.03.
Biopharma Credit plc Declares Interim Dividend in Respect of the Financial Period Ending 31 March 2024, Payable on 30 April 2024	21.03.
BioPharma Credit gets USD50.6 million from Abbvie's ImmunoGen purchase	13.02.
Biopharma Credit Secures $51 Million Loan Repayment from US Biotech ImmunoGen	13.02.
BioPharma Credit PLC Declares Interim Special Dividend in Respect of the Financial Period Ending 31 December 2023, Payable on 15 March 2024	08.02.
BioPharma Credit PLC Declares Ordinary Interim Dividend in Respect of the Financial Period Ending 31 December 2023, Payable on 15 March 2024	08.02.
Jefferies cuts BioPharma Credit to 'hold'	07.02.
Barratt takes over Redrow in GBP2.5 billion deal	07.02.
BioPharma Credit to receive partial prepayment of loan	06.02.
BioPharma Credit to fund LumiraDx ahead of acquisition by Roche	02.01.
BioPharma Credit : Resolution passed at General Meeting	28.12.
BioPharma Credit notes loan agreement amendment by LumiraDx	12.12.
BioPharma Credit notes AbbVie takeover of investee ImmunoGen	01.12.
Biopharma Credit plc Declares Special Dividend in Respect of the Financial Period Ended 30 September 2023, Payable on 5 January 2024	29.11.
BioPharma Credit PLC Declares Interim Dividend in Respect of the Financial Period Ended 30 September 2023, Payable on 5 January 2024	29.11.
BioPharma Credit says liquidity covenant in loan deal waived	12.10.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen BioPharma Credit PLC

Aktien

A2DN3S

GB00BDGKMY29

BPCP

Andere Sprachen

Filter